Trimethylamine N-Oxide and Related Metabolites in the Serum and Risk of Type 2 Diabetes in the Chinese Population: A Case-Control Study
Shenghong Qi,Lan Liu,Shulan He,Liqun Wang,Jiangping Li,Xian Sun
DOI: https://doi.org/10.2147/DMSO.S398008
2023-02-28
Abstract:Shenghong Qi, 1, 2 Lan Liu, 1, 2 Shulan He, 1, 2 Liqun Wang, 1, 2 Jiangping Li, 1, 2 Xian Sun 1, 2 1 School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China; 2 The Key Laboratory of Environmental Factors and Chronic Disease Control of Ningxia, Yinchuan, Ningxia, People's Republic of China Correspondence: Xian Sun, Tel +86 1 370 958 4072, Email Background: Trimethylamine N-oxide (TMAO) and its precursors have an association with type 2 diabetes mellitus (T2DM); however, the evidence is unclear. The current study examined the association of serial measures of serum TMAO and related metabolite concentrations with the risk of T2DM. Methods: Our study was designed as a community case-control study with 300 participants (150 T2DM and 150 non-T2DM). We examined the association of serum concentrations of TMAO and its related metabolites [trimethylamine, choline, betaine, and L-carnitine] using UPLC-MS/MS. The association between these metabolites and the risk of T2DM was analyzed using a restricted cubic spline and binary logistic regression. Results: A higher serum choline concentration was significantly associated with an increased risk of T2DM. Serum choline > 22.62 μmol/L was independently associated with an increased risk of T2DM, and the odds ratio was 3.615 [95% CI: (1.453,8.993), P = 0.006]. Similarly, serum betaine and L-carnitine concentrations had a markedly decreased risk of T2DM even after adjusting for the traditional risk factors for T2DM and betaine (0.978 [95% CI:0.964– 0.992], P = 0.002) and L-carnitine (0.949 [95% CI: 0.9222– 0.978], P = 0.001), respectively. Conclusion: Choline, betaine, and L-carnitine are associated with the risk of T2DM and may be appropriate risk markers to protect high-risk individuals from T2DM. Keywords: type 2 diabetes, T2DM, trimethylamine N-oxide, TMAO, betaine, choline, L-carnitine, trimethylamine N-oxide related metabolites A high prevalence of type 2 diabetes mellitus (T2DM) has been observed in China and worldwide, representing a major public health challenge in the 21st century. 1–3 According to the 10th edition of the International Diabetes Federation (IDF) Diabetes Atlas, approximately 790 million people worldwide have T2DM, with a steady increase in global incidence and prevalence over the past several decades, 90% of whom have T2DM. 4 Moreover, these patients experience microvascular and macrovascular complications from their condition, including diabetic kidney disease, retinopathy, and cardiovascular disease, with a direct cost increasing from USD 232 billion in 2007 to USD 966 billion in 2021. 4–6 Therefore, it is critical to reducing the direct and indirect losses caused by T2DM and its complications. Given the long-term harm of T2DM and the cost of implementing an intervention, there is a pressing need to accurately identify high-risk individuals early and better understand the etiology of T2DM for the design of new and effective interventions. A variety of factors influence the risk of type 2 diabetes, including lifestyle, environmental, and genetic factors. 7 They consistently increase the risk of developing T2DM. Early detection and treatment can prevent or delay the occurrence and development of diabetes. However, our understanding of the risk of diabetes remains incomplete. Recently, researchers focused on metabolites that can allow the identification of individuals at high risk for T2DM by monitoring their concentrations. 8 Trimethylamine N-oxide (TMAO) and its precursors, including trimethylamine (TMA), carnitine, choline, and betaine, play a significant role in glucose levels. 9–11 The results of a cohort study show that betaine was associated with a lower incidence of T2DM and a risk ratio of 0.50 (95% CI:0.32–0.80). 12 A meta-analysis showed a dose-dependent positive association between circulating TMAO levels, and increased risk of diabetes, with an odds ratio of 1.54. 13 In contrast, the atherosclerosis risk in communities (ARIC) study showed an association between T2DM and an increase in choline and betaine levels (HR:1.01, [95% CI 0.87–1.16] for choline; HR:1.01, [95% CI 0.94–1.10] for betaine) 14 were not significant. In the cardiovascular health study (CHS), TMAO and related metabolites did not show a statistically significant association with the risk of type 2 diabetes (HR: 1.20, [95% CI, 0.94–1.55] for TMAO; HR: 0.96, [95% CI, 0.74–1.24] for choline; HR: 0.88, [95% CI, 0.67–1.15] for betaine; HR: 1.07, [95% CI, 0.83–1.37] for carnitine; H -Abstract Truncated-
endocrinology & metabolism